NeuroSense Therapeutics Ltd. (NRSN) Reports FY results
Tweet
Share
E-mailGet Alerts NRSN Hot Sheet
Join SI Premium – FREE
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) reported FY EPS of ($0.54).
For earnings history and earnings-related data on NeuroSense Therapeutics Ltd. (NRSN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue
- Barrick Mining said to delay IPO of American gold business to 2027
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
